Applying standardized drug terminologies to observational healthcare databases: A case study on opioid exposure

Health Services and Outcomes Research Methodology

Volumn 13, Issue 1, 2013, Pages 58-67

  Defalco, Frank J ^a   Ryan, Patrick B ^a   Soledad Cepeda, M ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Classification systems; Coding standards; Drug exposures; Observational databases; OMOP

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; DOPAMINE UPTAKE INHIBITOR; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; OPIATE; ORAL ANTIDIABETIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CODING AND CLASSIFICATION; DRUG CLASSIFICATION; DRUG DATABASE; DRUG EXPOSURE; DRUG UTILIZATION; INFORMATION PROCESSING; MEDICAL RESEARCH; MEDICAL TERMINOLOGY; OBSERVATIONAL METHOD; PRIORITY JOURNAL; REPRODUCIBILITY; STANDARDIZATION;

EID: 84873575325     PISSN: 13873741     EISSN: 15729400     Source Type: Journal    
DOI: 10.1007/s10742-012-0102-1     Document Type: Article

References (44)

1. Ballantyne, J.C., Mao, J.: Opioid therapy for chronic pain. N. Engl. J. Med. 349(20), 1943-1953 (2003). doi: 10.1056/NEJMra025411 (Pubitemid 37409712)
2. Cepeda, M.S., Camargo, F., Zea, C., Valencia, L.: Tramadol for osteoarthritis: a systematic review and metaanalysis. J. Rheumatol. 34(3), 543-555 (2007) (Pubitemid 46364009)
3. Cepeda, M.S., Etropolski, M., Weinstein, R., Fife, D., Boston, R., Matcho, A.: Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United States. BMC Palliat. Care 9, 14 (2010). doi: 10.1186/1472-684X-9-14
4. Chen, S., Wu, N., Fraser, K., Boulanger, L., Zhao, Y.: Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments. Curr. Med. Res. Opin. 26(10), 2507-2516 (2010). doi: 10.1185/03007995.2010.518438
5. David, M., Adamson, P., Stella Chang, M., Leigh, G., Hansen, M.: MBA: Health Research Data for the Real World: The MarketScan. Database 6, 8 (2008)
6. Deshpande, A., Furlan, A., Mailis-Gagnon, A., Atlas, S., Turk, D.: Opioids for chronic low-back pain. Cochrane Database Syst. Rev. 3, CD004959 (2007). doi: 10.1002/14651858.CD004959.pub3 (Pubitemid 351805582)
7. Eisenberg, E., McNicol, E., Carr, D.B.: Opioids for neuropathic pain. Cochrane Database Syst. Rev. 3, CD006146 (2006). doi: 10.1002/14651858.CD006146
8. Enhanced therapeutic classification system. http://www.firstdatabank.com/ Products/therapeutic-classification-system-nddf.aspx (2011). Accessed 28 July 2011
9. Franklin, G.M., Stover, B.D., Turner, J.A., Fulton-Kehoe, D., Wickizer, T.M.: Early opioid prescription and subsequent disability among workers with back injuries: the disability risk identification study cohort. Spine (Phila Pa 1976) 33(2), 199-204 (2008). doi: 10.1097/BRS.0b013e318160455c
10. Furlan, A.D., Sandoval, J.A., Mailis-Gagnon, A., Tunks, E.: Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 174(11), 1589-1594 (2006). doi: 10.1503/cmaj.051528 (Pubitemid 43829515)
11. Gallagher, A.M., Leighton-Scott, J., van Staa, T.P.: Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study. Clin. Ther. 31(8), 1707-1715 (2009). doi: 10.1016/j.clinthera. 2009.08.022
12. Gasse, C., Derby, L., Vasilakis-Scaramozza, C., Jick, H.: Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy 20(6), 629-634 (2000) (Pubitemid 30387678)
13. Goettsch, W.G., Sukel, M.P., van der Peet, D.L., van Riemsdijk, M.M., Herings, R.M.: In-hospital use of opioids increases rate of coded postoperative paralytic ileus. Pharmacoepidemiol. Drug Saf. 16(6), 668-674 (2007). doi: 10.1002/pds.1338 (Pubitemid 47039533)
14. Gross, D.P., Stephens, B., Bhambhani, Y., Haykowsky, M., Bostick, G.P., Rashiq, S.: Opioid prescriptions in canadian workers' compensation claimants: prescription trends and associations between early prescription and future recovery. Spine (Phila Pa 1976) 34(5), 525-531 (2009). doi: 10.1097/BRS. 0b013e3181971dea
15. HCPCS general information. http://www.cms.gov/medhcpcsgeninfo/ (2011). Accessed 28 June 2011
16. i3 InVision Data Mart. http://www.i3global.com/content/File/10- 24269%20InVision%20Data%20Mart%20Prod%20sheet.pdf (2010). Accessed 25 July 2011
17. Iyer, S., Davis, K.L., Candrilli, S.: Opioid use patterns and health care resource utilization in patients prescribed opioid therapy with and without constipation. Manag. Care 19(3), 44-51 (2010)
18. Jick, H., Derby, L.E., Vasilakis, C., Fife, D.: The risk of seizures associated with tramadol. Pharmacotherapy 18(3), 607-611 (1998) (Pubitemid 28228343)
19. Kwong, W.J., Diels, J., Kavanagh, S.: Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain. Ann. Pharmacother. 44(4), 630-640 (2010). doi: 10.1345/aph.1M520
20. Martell, B.A., O'Connor, P.G., Kerns, R.D., Becker, W.C., Morales, K.H., Kosten, T.R., Fiellin, D.A.: Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann. Intern. Med. 146(2), 116-127 (2007) (Pubitemid 351640015)
21. Massey, G.M., Dodds, H.N., Roberts, C.S., Servoss, T.J., Blondell, R.D.: Toxicology screening in orthopedic trauma patients predicting duration of prescription opioid use. J. Addict. Dis. 24(4), 31-41 (2005) (Pubitemid 43334177)
22. ®). http://www.medi-span. com/master-drug-database.aspx (2011). Accessed 28 July 2011
23. National Drug Code Directory. http://www.fda.gov/Drugs/ InformationOnDrugs/ucm142438.htm (2011). Accessed 28 July 2011
24. National Drug File-Reference Terminology (NDF-RT). http://www.va.gov/trm/ StandardPage.asp?tid=5221&lob=1 (2011). Accessed 28 July 2011
25. National Formulary. http://www.pbm.va.gov/NationalFormulary.aspx (2011). Accessed 28 July 2011
26. Noble, M., Tregear, S.J., Treadwell, J.R., Schoelles, K.: Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J. Pain Symptom Manag. 35(2), 214-228 (2008). doi: 10.1016/j.jpainsymman.2007.03.015
27. OMOP Standard Terminologies. http://omop.fnih.org/vocabularies (2011). Accessed 25 July 2011
28. An Overview to RxNorm. http://www.nlm.nih.gov/research/umls/rxnorm/ overview.html (2011). Accessed 28 July 2011
29. Parente, S.T., Kim, S.S., Finch, M.D., Schloff, L.A., Rector, T.S., Seifeldin, R., Haddox, J.D.: Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. Am. J. Manag. Care 10(11 Pt 1), 783-790 (2004) (Pubitemid 39518523)
30. Pradel, V., Thirion, X., Ronfle, E., Masut, A., Micallef, J., Begaud, B.: Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database. Pharmacoepidemiol. Drug Saf. 13(7), 473-481 (2004). doi: 10.1002/pds.892 (Pubitemid 38996858)
31. Sittl, R., Nuijten, M., Nautrup, B.P.: Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study. Clin. Ther. 27(7), 1022-1031 (2005). doi: 10.1016/j.clinthera. 2005.06.024 (Pubitemid 41262460)
32. Skurtveit, S., Furu, K., Bramness, J., Selmer, R., Tverdal, A.: Benzodiazepines predict use of opioids - a follow-up study of 17,074 men and women. Pain Med. 11(6), 805-814 (2010). doi: 10.1111/j.1526-4637.2010.00870.x
33. Skurtveit, S., Furu, K., Bramness, J.G., Tverdal, A.: Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later-a follow-up study of 13,390 men and women aged 40-42 years. Pharmacoepidemiol. Drug Saf. 17(9), 926-933 (2008). doi: 10.1002/pds.1616
34. Stang, P.E., Ryan, P.B., Racoosin, J.A., Overhage, J.M., Hartzema, A.G., Reich, C., Welebob, E., Scarnecchia, T., Woodcock, J.: Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership. Ann. Intern. Med. 153(9), 600-606 (2010). doi: 10.1059/0003-4819-153-9-201011020-00010
35. Sullivan, M.D., Edlund, M.J., Fan, M.Y., Devries, A., Brennan Braden, J., Martin, B.C.: Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. Pain 150(2), 332-339 (2010). doi: 10.1016/j.pain.2010.05.020
36. Sullivan, M.D., Edlund, M.J., Fan, M.Y., Devries, A., Brennan Braden, J., Martin, B.C.: Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain 138(2), 440-449 (2008). doi: 10.1016/j.pain.2008.04.027
37. UMLS-Metathesaurus. http://www.nlm.nih.gov/research/umls/knowledge- sources/metathesaurus/index.html (2011). Accessed 26 July 2011
38. Victor, T.W., Alvarez, N.A., Gould, E.: Opioid prescribing practices in chronic pain management: guidelines do not sufficiently influence clinical practice. J. Pain 10(10), 1051-1057 (2009). doi: 10.1016/j.jpain.2009.03.019
39. Voaklander, D.C., Rowe, B.H., Dryden, D.M., Pahal, J., Saar, P., Kelly, K.D.: Medical illness, medication use and suicide in seniors: a population-based case-control study. J. Epidemiol. Community Health 62(2), 138-146 (2008). doi: 10.1136/jech.2006.055533 (Pubitemid 351196854)
40. Von Korff, M., Merrill, J.O., Rutter, C.M., Sullivan, M., Campbell, C.I., Weisner, C.: Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain 152(6), 1256-1262 (2011). doi: 10.1016/j.pain.2011.01.005
41. White, L.A., Robinson, R.L., Yu, A.P., Kaltenboeck, A., Samuels, S., Mallett, D., Birnbaum, H.G.: Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia. J Pain 10(9), 976-983 (2009). doi: 10.1016/j.jpain.2009.03.012
42. WHOCC-Structure and principles. http://www.whocc.no/atc/structure-and- principles/ (2011). 2011
43. Ytterberg, S.R., Mahowald, M.L., Woods, S.R.: Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 41(9), 1603-1612 (1998). doi: 10.1002/1529-0131(199809)41:9<1603:AID-ART10>3.0. CO;2-U (Pubitemid 28459918)
44. Zorowitz, R.D., Smout, R.J., Gassaway, J.A., Horn, S.D.: Usage of pain medications during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP). Top Stroke Rehabil. 12(4), 37-49 (2005). doi: 10.1310/C7MF-VLR0-CKDL-3C44 (Pubitemid 43132702)